About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« An Article That Shows What Med-Chem Is Like? | Main | Anti-GMO. Until This Week. »

January 4, 2013

Science Fraud and Legal Action

Email This Entry

Posted by Derek

There have been occasional links here in the comments to, although I'm not sure if I ever linked them directly or not. Note the use of the past tense: as detailed here at Retraction Watch, the site has suddenly gone (mostly) dark under threats of legal action. Nothing appears on the Wayback Machine at, either.

I'm not all that surprised. I've said unkind things about people and organizations on this blog, but Science Fraud seemed to have that pedal pushed down to the floor the entire time. And while I've had threats of legal action, I think that I've managed to stay just this side of defamation, although with some people that's hard to do. (I mean for that to be interpreted both ways - both that it's hard to avoid saying nasty things about some people, but also that in such cases, it's hard to think of things that are nasty enough to be defamatory). But which side of that line Paul Brookes, the now-public U. Rochester scientist behind the Science Fraud site, has landed on is still up for debate. More as this story develops. . .

Comments (4) + TrackBacks (0) | Category: The Dark Side | The Scientific Literature


1. fat old man on January 4, 2013 11:49 AM writes...

As I drill down one of the links I see a reference to Ben Goldacre as some kind of good guy. I just want to point out that his 2008 book 'Bad Science' has a chapter skewering the pharmaceutical industry that is based on erroneous information on how the industry works. It sounds like he is an expert but it is clear to anyone with any experience in the business that he does not have a clue. Since this post is about something else I will stop there, but I'll be glad to elaborate.

Permalink to Comment

2. Another Derek on January 4, 2013 8:14 PM writes...

Looking at your "threats of legal action" internal link I saw Nativis, and looking at a few minutes ago I saw a one-page website touting Nativis Voyager, "a medical device that replaces standard chemotherapy with specific low level radio frequency energy (RFE)", said to be "in veterinary clinical trials to treat naturally occurring solid tumors in canine patients". So much for the 2010 IND.

Permalink to Comment

3. Wesley on January 15, 2013 9:01 AM writes...

@Fat Old Man...Ben Goldacre is right about pharma. Of course the industry says he doesn't know what he is taking about, because they are committing the science crimes.

Just go to a prison and ask for a guilty person..

Permalink to Comment

4. Lindsay on February 25, 2013 8:07 PM writes...

"fat old man": Please do...

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry